pubmed-article:15305405 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0194810 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0445204 | lld:lifeskim |
pubmed-article:15305405 | lifeskim:mentions | umls-concept:C0430420 | lld:lifeskim |
pubmed-article:15305405 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15305405 | pubmed:dateCreated | 2004-8-12 | lld:pubmed |
pubmed-article:15305405 | pubmed:abstractText | Recent studies have shown that a significant number of men with normal prostate-specific antigen (PSA) levels have prostate carcinoma. Whether malignancies in such men are associated with better outcomes is unclear. The authors compared the risk of biochemical failure after radical prostatectomy (RP) between men with normal PSA levels and men with elevated PSA levels. | lld:pubmed |
pubmed-article:15305405 | pubmed:language | eng | lld:pubmed |
pubmed-article:15305405 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15305405 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15305405 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15305405 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15305405 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15305405 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:FreedlandStep... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:AronsonWillia... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:TerrisMartha... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:KaneChristoph... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:PrestiJoseph... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:AmlingChristo... | lld:pubmed |
pubmed-article:15305405 | pubmed:author | pubmed-author:TrockBruceB | lld:pubmed |
pubmed-article:15305405 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15305405 | pubmed:day | 15 | lld:pubmed |
pubmed-article:15305405 | pubmed:volume | 101 | lld:pubmed |
pubmed-article:15305405 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15305405 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15305405 | pubmed:pagination | 748-53 | lld:pubmed |
pubmed-article:15305405 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:meshHeading | pubmed-meshheading:15305405... | lld:pubmed |
pubmed-article:15305405 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15305405 | pubmed:articleTitle | Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. | lld:pubmed |
pubmed-article:15305405 | pubmed:affiliation | Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287-2101, USA. sfreed1@jhmi.edu | lld:pubmed |
pubmed-article:15305405 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15305405 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:15305405 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15305405 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15305405 | lld:pubmed |